Select Category for: Listings

April 28, 2026 | 4 min read • 465 views
India’s REIT Yield War: Can Bagmane Beat Embassy & Brookfield at Their Own Game?

A deep-dive into India’s REIT yield landscape—compare Embassy, Brookfield, Mindspace, Nexus, and the upcoming Bagmane REIT. Discover real yields, hidden risks, and whether this IPO could redefine income investing in India

April 28, 2026 | 5 min read • 148 views
OnEMI IPO Decoded: India’s Next Big Fintech Bet or a Hidden Credit Risk?

OnEMI Technology Solutions IPO explained with full data-backed analysis—financials, valuation, peer comparison, risks, and subscription strategy. Is this fintech IPO worth your money

April 8, 2026 | 4 min read • 1102 views
Om Power Transmission IPO: Strong Orders… But Where’s the Cash?

Om Power Transmission IPO review: Strong ₹744 Cr order book vs rising working capital risk. Should you apply? Full data-backed analysis

March 25, 2026 | 3 min read • 1316 views
🧪 Sai Parenterals IPO: ₹408 Cr Pharma Bet Trading at 70–110x — Growth Story or Overvaluation?

Sai Parenterals IPO analysis with RHP data: financials, valuation (70–110x P/E), risks, and growth outlook. Should you invest or avoid? Full forensic breakdown

March 25, 2026 | 4 min read • 1239 views
⚡ Powerica IPO: Balance Sheet Fix or Strategic Energy Play?

Powerica IPO analysis 2026: Deep dive into financials, RHP insights, valuation, risks, peer comparison, and listing outlook. Should you apply or avoid? Read this expert breakdown before investing

February 25, 2026 | 4 min read • 1522 views
Clean Max Enviro Energy IPO Analysis: Deleveraging Renewable Platform or High-Risk Infra Bet?

A deep institutional analysis of Clean Max Enviro Energy Solutions IPO covering valuation, leverage risk, C&I renewable positioning, peer comparison, and long-term investment outlook for serious investors

February 25, 2026 | 4 min read • 1422 views
Gaudium IVF IPO Analysis: Growth Opportunity in India’s Fertility Boom or High-Risk Expansion Bet?

Comprehensive Gaudium IVF IPO analysis covering valuation, bull vs bear case, listing gain potential, risks, and long-term investment outlook

February 7, 2026 | 4 min read • 1651 views
Aye Finance IPO: Premium Deep-Dive for Informed Investors

In-depth Aye Finance IPO analysis covering valuation vs peers, price band impact, risks, and retail vs HNI subscription strategy to help investors decide wisely

February 7, 2026 | 4 min read • 1873 views
Fractal Analytics IPO Review: India’s First AI IPO – Hype, Quality, or Valuation Trap?

Fractal Analytics IPO analysis from a fund-manager lens. Deep dive into valuation, DRHP risks, client concentration, ESOP dilution, GMP outlook, and whether investors should apply or avoid this AI-led services IPO

January 14, 2026 | 4 min read • 1858 views
Shadowfax Technologies IPO: Should Retail Investors Subscribe or Wait?

Shadowfax Technologies IPO detailed review covering valuation modeling, peer comparison, risks, margin sensitivity, and a clear retail investor decision framework